HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
LEGN
Legend Biotech Corp
Healthcare Biotechnology ADR · New Jersey, USA · Reports in usd
Market Cap: $4.05B
Market Cap
$4.05B
Enterprise Val
$3.37B
P/E Ratio
-44.20
P/B Ratio
3.30
Trailing PEG (1Y)
0.35
As Of
Aug 20, 2026

Overview & Key Metrics

Reporting period: Jun 30, 2026 · Q2 2026
Book Value$1.23B
Gross Margin64.54%
Profit Margin64.54%
Return on Equity-8.71%
Return on Assets-5.40%
Current Ratio3.04
Debt/Equity0.23
LT Debt/Equity0.09
Revenue Per Share2.09

Income Statement

Jun 30, 2026
Revenue$387.5M
Cost of Revenue$137.4M
Gross Profit$250.1M
R&D$96.0M
SG&A$96.4M
Operating Expenses$192.4M
Operating Income$57.7M
Interest Expense$5.8M
Tax Expense$22.3M
Net Income$33.2M
EPS (Basic)$0.18
EPS (Diluted)$0.18
EBIT$61.3M
EBITDA$73.0M
Consolidated Income$33.2M
Non-Controlling Interests$0.00

Balance Sheet

Jun 30, 2026
Cash & Equivalents$964.6M
Accounts Receivable$0.00
Inventory$41.5M
Current Assets$1.23B
LT Investments$0.00
Property, Plant & Equipment$448.2M
Intangibles$0.00
Non-Current Assets$523.5M
Total Assets$1.75B
Accounts Payable$199.9M
Current Debt$168.2M
Current Liabilities$403.6M
LT Debt$110.0M
Non-Current Liabilities$117.7M
Total Liabilities$521.3M
Total Debt$278.2M
Shareholder Equity$1.23B
Shares Outstanding371,479,583

Cash Flow Statement

Jun 30, 2026
Operating Cash Flow-$20.9M
Investing Cash Flow-$120.0M
Financing Cash Flow$167.7M
CapEx-$7.5M
Free Cash Flow-$28.4M
Depreciation & Amort.$11.7M
Stock-Based Comp$17.4M
Acquisitions / Disposals-$13.1M
Investment Activity-$99.4M
Debt Issued/Repaid-$44.9M
Equity Issued/Repaid$212.6M
Net Change in Cash$26.5M
Data cached · Meta cache · Daily cache · Statements cache · TTL 24h